ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Supply chain & Buy American issues (COVID-19 related) Importation
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| HELEN DWIGHT | — |
| THADDEUS FLOOD | — |
| AARON W HUNTER New | Sen. Kent Conrad (ND), Special Assistant and Staff Assistant (Feb 2001- April 2005 |
| CAROLINE QUAT | NA |
| STEPHANIE WISWALL | — |
Health Issues HCR
Value of Prescription Drugs Drug Pricing Transparency S. 1895, Lower Health Care Costs Act COVID-19 Vaccine and Therapy Development COVID-19 response packages * Healthcare policy & reimbursement *FY2021 Omnibus and COVID Relief and Response Act - H.R. 133, H. Rules Comm. Print 116-68 *Discussions related to a possible increase in the Federal average manufactures price cap
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| HELEN DWIGHT | — |
| THADDEUS FLOOD | — |
| AARON W HUNTER New | Sen. Kent Conrad (ND), Special Assistant and Staff Assistant (Feb 2001- April 2005) |
| CAROLINE QUAT | NA |
| STEPHANIE WISWALL | — |
Medicare/Medicaid MMM
Medicare Part D & B Coverage and Reimbursement Legislative proposals to change Medicare Part D Changes to the Medicaid Drug Rebate Program (AMP Cap) Medicaid drug pricing reporting H.R. 107, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs ESRD PPS, Medicare coverage ANPRM International Pricing Index Model for Medicare Part B Drugs Proposed Rule: Medicaid Program: Establishing Minimum Standards in Medicaid State Drug Utilization * Medicaid and 340B issues & drug discount program *Importation and Most Favored Nations * H.R.8845, Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| HELEN DWIGHT | — |
| THADDEUS FLOOD | — |
| AARON W HUNTER New | Sen. Kent Conrad (ND), Special Assistant and Staff Assistant (Feb 2001- April 2005) |
| CAROLINE QUAT | NA |
| STEPHANIE WISWALL | — |
Pharmacy PHA
Medicare Part D coverage and reimbursement Value of Prescription Drugs Innovative Payment Model (VBAs) Price Transparency Medicaid and 340B issues & drug discount program H.R. 1499, Protecting Consumer Access to Generic Drugs Act S. 1416, Affordable prescriptions for Patients Act H.R. 107, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs ANPRM: Importation of Prescription drugs and Most Favored Nations
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| HELEN DWIGHT | — |
| THADDEUS FLOOD | — |
| AARON W HUNTER New | Sen. Kent Conrad (ND), Special Assistant and Staff Assistant (Feb 2001- April 2005 |
| CAROLINE QUAT | NA |
| STEPHANIE WISWALL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.